DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next
DaVita shares rose nearly 20% to $132.98 after the company projected 2026 adjusted earnings per share of $13.60–$15.00, above analyst estimates. Fourth-quarter adjusted EPS reached $3.40 on revenue of $3.62 billion, both topping forecasts. The company cited higher reimbursement rates and a seasonal boost from flu vaccines. DaVita flagged a $40 million hit in 2026 from expiring ACA subsidies.